Global Healthcare Cold Chain Logistics Market Report 2020 with COVID-19 Impact Analysis – Vaccine Segment Expected to Reach $7.1 Billion by 2027 – ResearchAndMarkets.com | Business

Global Healthcare Cold Chain Logistics Market Report 2020 with COVID-19 Impact Analysis – Vaccine Segment Expected to Reach $7.1 Billion by 2027 – ResearchAndMarkets.com | Business


DUBLIN–(BUSINESS WIRE)–Oct 12, 2020–

Global Healthcare Cold Chain Logistics Market to Reach $18.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Cold Chain Logistics estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$18.5 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027.

Vaccines, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$7.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Clinical Trial Materials segment is readjusted to a revised 7.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 11% CAGR

The Healthcare Cold Chain Logistics market in the U. S. is estimated at US$3 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2027 trailing a CAGR of 11% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Biopharmaceuticals Segment to Record 8% CAGR

In the global Biopharmaceuticals segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.5 Billion by the year 2027, while Latin America will expand at a 9.4% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

  • Global Competitor Market Shares
  • Healthcare Cold Chain Logistics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

GEOGRAPHIC MARKET ANALYSIS

  • Market Facts & Figures
  • US Healthcare Cold Chain Logistics Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • Market Facts & Figures
  • European Healthcare Cold Chain Logistics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • Total Companies Profiled: 44

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 10/12/2020 05:36 AM/DISC: 10/12/2020 05:36 AM

Copyright Business Wire 2020.



Source link Google News

Share